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Abstract
Background: Transcatheter closure of atrial septal defect (ASD) in older children and adults 
is currently considered the first-choice therapeutic option. This approach remains challenging 
in younger children. The aim of the study was to evaluate feasibility, safety and midterm effica-
cy of percutaneous ASD closure in symptomatic infants £ 10 kg body weight in our institution.
Methods: There were 28 children up to 10 kg of body weight, who were qualified for trans-
catheter closure of ASD. All patients but one showed overload of right atrium and right ventricle.  
Mean weight of patients who underwent transcatheter closure was 9.2 ± 0.88 kg and age 
1.59 ± 0.58 years, respectively. Transcatheter closure of ASD was conducted using Amplatzer 
occluders (ASO).
Results: The devices were implanted successfully in 26/28 patients (93%). In 2 (7%) children 
the device repeatedly straddled the septum in relatively big ASD and the procedure was abando-
ned. Mean ASD diameter in patients, who underwent transcatheter closure, was 9.08 ± 2.9 mm  
(transthoracic echocardiography) and mean implant size/weight ratio was 1.07 ± 0.31. In the 
child with right-left shunt through ASD normalization of saturation occurred. Mean fluoroscopy 
time was 4.16 min. In 3 children minor complications occurred: transient arrhythmias (n = 1),  
fever after procedure (n = 2). The follow-up time was 6.1 (range 1.2–11) years. At follow-up, 
clinical condition and/or growth improved in all patients except 4 children with coexisting 
comorbidity. No arrhythmia nor conduction disturbances were observed during follow-up.
Conclusions: In selected patients weighing less or equal to 10 kg, percutaneous closure of ASD 
is a safe and effective procedure. (Cardiol J 2014; 21, 3: 279–283)
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Introduction
Atrial septal defect of type II (ASD) is one of 
the most common congenital heart defects occur-
ring in children and makes 8–10% of all congenital 
heart defects. 75% ASD cases are placed in the 
region of fossa ovalis. The size of the defect can 
range from a small fenestration to a complete lack 
of the septum. The major element of the defect is 
most often a left-right shunt. Although ASD closure 
is recommended in the childhood, the diagnosis 
is often set in adult patients in the third or fourth 
decade of life when heart insufficiency or rhythm 
disorders are manifested.
However, it happens that the symptoms of he-
modynamically significant ASD, such as recurring 
infections of the upper airways, impaired child de-
velopment (small weight growth), decreased effort 
tolerance, or cardiac insufficiency occur even in 
small children. In some cases, the unclosed defect 
can lead to irreversible, progressive disease — 
pulmonary hypertension (Eisenmenger syndrome).
The procedure of ASD closure is made accor-
ding to a plan respecting standards usually when 
a child is 4 years old [1–3], however in younger 
patients with clinical symptoms of heart defects, 
the intervention date should be hastened. Hemo-
dynamically significant left to right shunt with 
pulmonary/systemic flow ratio — Qp/Qs > 1.5 is 
a classical indication for ASD closure. In clinical pra - 
ctice, symptoms of right atrium (RA) and right ven-
tricle (RV) volume overload in echocardiography is 
an indication for ASD closure. Percutaneous ASD 
closure is presently considered to be a therapeutic 
option of the first choice. These procedures are 
a challenge in younger children. For practical pur-
poses, any defect of 8 mm or larger with evidence of 
significant left to right shunt should be closed when 
identified, even in very young patients, because 
such a defect will likely never close spontaneously 
and may in fact even get larger [4, 5].
The aim of this study was to analyze the 
results, efficacy and safety of the percutaneous 
closure of symptomatic ASD in children with body 
mass up to 10 kg. Present reports on this subject 
are scarce [6–15]. The group of children described 
in this study is one of the most numerous we have 
found in the literature available.
Methods
Description of the study group
The procedure of percutaneous ASD closure 
has been performed in our Center since October 
1997. Since then, we have made 1180 procedures. 
From April 2002 to December 2011, 28 children 
were qualified for this type of intervention (22 girls 
and 6 boys) with body mass up to 10 kg.
In all patients (apart from one child with bor-
derline hypoplastic RV and tricuspid incompetence) 
overload of right cardiac cavities was found. All 
the interventions were performed in the Cathlab 
of Congenital Heart Diseases and Pediatric Car-
diology Ward, Silesian Centre of Heart Diseases 
in Zabrze. The implant Amplatzer Atrial Septal 
Occluder (ASO) by AGA Medical Corp (USA) was 
used in all the procedures.
The intervention was successfully performed 
in 26 children at the age of 0.5–2.8 years, mean 
1.59 ± 0.58 years. In 2 cases the percutaneous 
closure was canceled due to persistent slanting 
opening of the implant in the big ASD. Children’s 
body mass was 6.5–10 kg (mean 9.2 ± 0.88 kg). 
In 18 children single ASD was present, while in 
10 patients multiple defects were found. There 
were 6 patients with multiperforated aneurysm of 
interatrial septum and 4 patients with small addi-
tional fenestration located close to the main defect. 
One patient (with borderline RV hypoplasia) had 
previous surgery of complex cyanotic heart defect 
(RVOT reconstruction, right-sided Blalock-Tausig 
anastomosis and PDA ligation).
Additional heart defects occurred in 3 patients; 
as mentioned above, one patient had pulmonary 
valve atresia with intact ventricular septum, the 
second had a small ventricular septal defect and the 
third had pulmonary valve stenosis. This patient 
had pulmonary balloon valvuloplasty performed 
before ASD closure during the same procedure. 
General qualification criteria for the intervention 
were significant symptoms of left-right shunt 
through ASD with overload of RA and RV. One 
patient (with hypoplastic RV) had right-left shunt 
with central cyanosis (saturation 79%).
The interview in the study group showed the 
following symptoms: body mass deficiency (below 
or equal 25 centiles) — 19 children, sweating, 
fatigability while eating — 7 children, recurring 
infections of respiratory tract — 6 children (in 
one, recurring obturative bronchitis and nephro-
pathy were found). One child’s history revealed 
premature birth with hypotrophy (birth body mass 
870 g) and some other disorders. Moreover, one 
child was diagnosed with fetal alcohol syndrome 
and another with Down syndrome. The important 
factor enhancing the qualification of children for 
transcatheter ASD closure were insistent parents’ 
requests for an intervention.
The intervention was cancelled when ASD 
was not hemodynamically significant, anatomy 
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was unfavorable (lack of posterior or posterior-
-inferior septal rim — 2 children) or defects were 
multiple of unfavorable localization or ASD was 
accompanied by other cardiac defects requiring 
surgical correction.
Procedural details
All the interventions of transcatheter ASD 
closure in children up to 10 kg were performed in 
the hemodynamic laboratory in general anesthesia 
with endotracheal intubation and antibiotic cover. 
Standard application of heparin 100 µ/kg before 
the procedure and cefazolinum in 3 doses every 
8 h were used. Then, constant infusion of heparin 
300 µ/kg/24 h was administered under activated 
partial thromboplastic time control. The ASD 
closure was performed under fluoroscopic and 
transesophageal echocardiography (TEE) guidance 
according to the defined guidelines [16]. Necessary 
condition for transcatheter ASD closure was the 
presence of atrial septal rims (at least 5 mm) in 
order to obtain a stable implant position. The ex-
ception was aortal rim which could be deficient. Ho-
wever, if it was accompanied additionally by other 
deficient or floppy rim, a patient was disqualified 
from transcatheter treatment and was directed to 
surgical correction.
The size of the defect in all the procedures was 
evaluated in two parallel projections.
The implant size was selected either on the ba-
sis of the defect stretch diameter or with reference 
to defect diameter defined by TEE (it was equal or 
2–3 mm bigger than the biggest measurement in 
this examination). Catheter calibration was omitted 
in 4 children with multi-fenestrated aneurysm of 
interatrial septum (size of the implant was equal 
to the entrance of aneurysm) and in 11 children 
with centrally located defect with good surroun-
ding rims. During the intervention, the occluder 
was loaded onto a special delivery system and was 
transported through a long sheath introduced from 
femoral vein to the right and left atrium through 
the defect. Then, the left-atrial disc was opened, 
the implant was pulled to atrial septum obtaining 
support and then right-atrial disc was deployed. 
After occluder insertion, before its release, a pre-
cise evaluation of the implant position was made 
using TEE. In some cases the “Minnesota wiggle” 
maneuver was used by pushing and then pulling 
the device in order to make sure that the implant 
is located properly in the atrial septum. The device 
was released in all the cases by unscrewing from 
the leading system after echocardiography and 
fluoroscopy which confirmed its proper position. 
When the occluder’s position was not satisfactory, 
a reposition was made by retracting one or 2 discs 
into the sheath and deploying them again.
The intervention’s result (implant stability, 
residual shunt) was evaluated by TEE during the 
procedure and afterwards — transthoracic echo-
cardiography (TTE) was used. After the procedure 
aspirin in dosage 3–5 mg/kg during 6 months was 
applied.
Control examinations (ECG and TTE) were 
performed in the 1st, 3rd, 6th, 12th months after the 
procedure and then annually.
The study was approved by the local bioethi-
cal committee and all parents gave their informed 
consent.
Results
The intervention was effective in 26/28 pa-
tients (93%). In 2 children the procedure was 
abandoned due to a relatively big defect and obli-
que position of the implant in its lumen. Their age 
was 1.3 and 1.5 years. The ASD diameter in TEE 
in the patients who underwent successful closure 
ranged from 4 mm to 16 mm, mean 9.08 ± 2.9 mm. 
In 11/26 children (42.3%) the defect diameter 
(“stretch”) was estimated by balloon sizing and 
was 11.36 ± 3.8 mm. In all the procedures ASO 
implants (AGA Med. Corp. USA) of the diameter 
from 5 to 16 (mean 10.42 ± 2.73) mm were used 
by application of 6 F or 7 F introducer. Body mass 
[kg] to implant diameter [mm] ratio ranged from 
0.5 to 1.56, mean 1.07 ± 0.31. In 13/26 children (50%) 
it was equal or exceeded the value of 1.2. There 
was no ASO embolization in any case, nor during 
or after the procedure. Mean fluoroscopy time was 
4.2 (from 1.0 to 11.0) min, mean procedure time 
was 48 (from 20 to 90) min depending mainly on 
the time of TEE examination. The implantation was 
effective at the first deployment in 24/26 patients. 
In 1 patient, only third reposition was effective 
(oblique implant position in ASD). In this case the 
method included using a dilatator inserted from 
the opposing femoral vein in order to stabilize the 
upper part of left-atrium disc on the left side of 
interatrial septum, the implant was inserted into 
the upper right pulmonary vein and the left-atrial 
disc was opened there together with simultaneous 
opening of the right atrial disc with a proper pulling 
movement of the delivery system. Unfortunately, 
these maneuvers were unsuccessful in 2 (7%) 
children qualified to transcatheter ASD closure. 
The procedure was interrupted due to unfavorable 
anatomy of the defect (the implant was deployed 
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incorrectly on the atrial septum several times) 
and the patients were referred to cardiosurgical 
treatment.
One child had a short episode of supraventri-
cular tachycardia in the postoperative period, which 
disappeared spontaneously. One child, despite ef-
fective closure of the defect at the first trial, remo-
ved the tracheal tube during the intervention and 
it was impossible to evaluate the implant position 
near aortal valve. A correct position of the occluder 
was confirmed by TTE. One child simultaneously 
to ASD closure had successful pulmonary ballo-
on valvuloplasty (gradient decreased from 70 to 
23 mm Hg). Two children got infection in the post-
-procedural period. One had 3-day fever with the 
temperature 38oC, another had upper respiratory 
tract infection. Both were given antibiotic cover — 
the first one — cefazolin, the other — cefuroxime.
The follow-up period was 6.1 (from 1.2 to 11) 
years. During this period residual atrial shunt 
was found in 10 (38.4%) patients directly after the 
intervention, in 8 (30.8%) patients 24 h after the 
procedure, in 5 (19.2%) patients within 1 month 
after the procedure, in 2 (7.7%) patients within 
3 months after the procedure and in 1 (3.85%) 
a very trivial one, 12 months after the procedure. 
In all children who had transcatheter ASD closure 
(except for one with RV hypoplasty) decreased 
dimensions of RA and RV were found in echocardio-
graphy already 3 months after the intervention. In 
a child with RV and tricuspid valve hypoplasty with 
right-left shunt through ASD, an increased right 
cardiac cavity, improved normalization of blood 
saturation and enhanced physical development 
were observed after the intervention.
Better appetite, regression or decrease of car-
diac failure, lower susceptibility to upper airways 
infections were observed in all the children. Mo-
reover, much better weight growth was observed 
and as a consequence the age/weight index went 
up on the centile nets (Fig. 1).
This index decreased in 1 child with a non-
-cardiac morbidity. The child had other coexisting 
allergic and nephrologic diseases. Weaker deve-
lopment persisted in 3 children (below 10 percen-
tile), 1 child with fetal alcohol syndrome, the other 
with very low birth weight and another with Down 
syndrome. No rhythm nor conduction disorders 
were observed in any of the patients.
Discussion
According to the presented results, trans-
catheter ASD closure is a feasible and effective 
method even in the youngest group of children, i.e. 
with the body weight up to 10 kg, even in infants. 
To perform this procedure we applied Amplatzer 
occluders. The advantages of this device are: the 
biggest experience with the use of them and the 
smallest delivery systems necessary for implan-
tation. The latter is of great importance in small 
children whose vessel size is tiny.
Generally, there is a consensus that signifi-
cant ASD should be closed, but there are different 
opinions when to do it. The reason for this is 
a theoretical chance of spontaneous closure of the 
defects as the child grows. It is also the main reason 
for postponing the intervention, usually according 
to the majority of experts’ opinions, to the age from 
3 to 5 years [1–4].
On the other hand, it should be stressed that 
published data demonstrated tendency to increase 
diameter of big ASD with time in observation pe-
riods in children. This fact can sometimes be an 
obstacle to further non-surgical treatment. There-
fore, there is an agreement that small defects tend 
to close spontaneously, while the bigger ones — to 
increase [5].
Present reports on transcatheter ASD closure 
in small children are scarce and only a few refer to 
the group with a body weight below 10 kg [6–15]. 
The population described in this study is one of the 
biggest groups treated by this method in the world.
On the basis of the results, a thesis can be 
formulated that most of these children show the 
improvement of physical development, cardiac 
indices normalization and regression or significant 
decrease of accompanying morbidity. Our expe-
Figure 1. Body weight (in percentiles) before (0) and 
after (1–72 months) transcatheter atrial septal defect 
(ASD) closure in 15 children with weight up to 10 kg 
during procedure and at least 6-year follow-up.
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riences contradict those published recently by 
a group of researchers from Houston, who stated that 
better results can be achieved in children whose 
implant size and body weight ratio is smaller than 
1.2 (in our material such a group consisted of 50% 
patients) [6]. This can be a result of the older age 
of children in their study [6]. Moreover, our ini-
tial experience indicates that the method can be 
effective and clinically favorable in patients with 
a complex defect with right-left shunt through the 
ASD. According to our assumptions, early closure 
of ASD II in small children should result, together 
with a child’s growth, in a decrease of the implant 
diameter and septum length ratio and should im-
prove the heart hemodynamics in the future (in 
cases of larger defects closure in older children or 
adults, “stenting” of the whole atrial septum with 
a nitinol plug often takes place).
Transcatheter ASD closure in small children 
requires an experienced operator due to potential 
technical problems. An intervention cardiologist can 
encounter problems related to small vessel dimen-
sions, or with defect calibration with a balloon cathe-
ter during ASD closure in children with a weight up 
to 10 kg. These balloons are generally dedicated by 
producers for adult patients — but this method was 
unnecessary and omitted in majority of our children. 
Moreover, small heart dimensions, relatively small 
atrial septum, make catheter maneuvers difficult. 
Furthermore, available delivery catheters (with 
45 degrees ending of the long sheath) do not make 
the procedure easier, often causing oblique position 
of the implant in relation to the septum. In such 
a situation, some of the techniques that we applied 
in our patients can be helpful.
Limitations of the study
Our study has its limitations. At first it was 
a retrospective analysis and there existed a lack of 
specific symptoms of left to right shunt in this he-
terogeneous population. Documented gain weight 
and relief of symptoms after ASD closure suggest 
that the defect had played a prominent role in the 
clinical state, although this could not be fully de-
monstrated. The number of patients was too small 
to correctly evaluate the risk for minor or major 
complications.
Conclusions
The results presented above show that safety, 
efficacy and medium-length results of transcathe-
ter ASD closure performed in small children are 
high and very promising. It can be the reason for 
changing the binding directives, i.e. move the in-
dications to transcatheter ASD closure to children 
of an earlier age.
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